CHICAGO--The quest for a clear way forward in neurodegenerative imaging and therapeutics continues, with many of the same challenges continuing from previous years, according to a neuroimaging symposium during the Radiological Society of North America’s (RSNA) 99th annual meeting.

A number of exhibitors in attendance at last week’s Radiological Society of North America (RSNA) annual meeting in Chicago presented milestones in dose-technology development and hospital integration.

CHICAGO—PET/MR hybrid scanners represent a leap forward for cardiac imaging, but technical challenges and reimbursement hurdles still limit widespread clinical use, according to a presentation at the annual meeting of the Radiological Society of North America (RSNA).

All major manufacturers of molecular imaging technologies now have PET/MR systems in their product portfolios. While Siemens is the only company to have an FDA approved, simultaneous PET/MR system on the market, a number of reports indicate that GE Healthcare is not too far behind in the research and development phase of an on-board and fully integrated PET/MR scanner, as evidence would have it at the 2013 Radiological Society of North America (RSNA) annual meeting still underway in Chicago until its conclusion tomorrow.

CHICAGO—Digital breast tomosynthesis (DBT) has been shown to reduce recall rates and increase the detection rates of breast cancer, according to research presented Dec. 3 at the annual meeting of the Radiological Society of North America (RSNA).

CHICAGO—Recent CMS decisions related to oncologic use of FDG and amyloid imaging have already left their mark on the radiopharmaceutical industry, according to major market stakeholders at this year's Radiological Society of North America (RSNA) meeting. 

CHIICAGO—Automated volumetric breast density measurement is predictive of breast cancer in young women and the risk of breast cancer may be related to an altered pattern of breast density regression with age, according to research presented Dec. 3 at the annual meeting of the Radiological Society of North America (RSNA).

CHICAGO—The disciplines of radiomics and genomics are being spliced for specialized tumor mapping that moves toward a less invasive, higher-tech supplement, and perhaps one day an alternative to biopsy, according to a molecular imaging symposium presented Dec. 2 at the Radiological Society of North America’s (RSNA) 99th annual meeting.